Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Neurological Surgery. Part A, Central European Neurosurgery|February 22, 2013
Recurrent adult choroid plexus carcinoma treated with high-dose chemotherapy and syngeneic stem cell (bone marrow) transplantThomas A Samuel, Jigarkumar Parikh, Suash Sharma, et al.
Hematology Reports|November 24, 2025
Outcomes for Primary Central Nervous System Lymphoma from a Single InstitutionSruthi Dontu, Jacob Boccucci, Michael Chahin, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2024
Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m<sup>2</sup> versus 140 mg/m<sup>2</sup>Zachary Brown, Campbell Scott, Li Fang Zhang, et al.
Leukemia|September 11, 2025
Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemiaMarisol Miranda-Galvis, Kellen C Tjioe, Muhannad Sharara, et al.
Therapeutic Advances in Hematology|January 3, 2017
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinibSikander Ailawadhi, Luke P Akard, Carole B Miller, et al.
Cancer|November 13, 2014
Predicting early blast transformation in chronic-phase chronic myeloid leukemia: is immunophenotyping the missing link?Fuad El Rassi, John D Bergsagel, Martha Arellano, et al.
Leukemia Research|November 7, 2008
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816VCelalettin Ustun, Christopher L Corless, Natasha Savage, et al.
Scientific Reports|October 18, 2017
A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expressionAbhishek Mangaonkar, Ashis Kumar Mondal, Sadanand Fulzule, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2012
Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapiesMehdi Hamadani, S Thomas Kochuparambil, Salman Osman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cellsWarren Fiskus, Yongchao Wang, Rajeshree Joshi, et al.
Pageof 3